Announcement of BOD’s resolution to lift the non-competition restrictions for new CEO

Announcement of change of CEO

Announcement of change of the spokesperson

Announcement of change of Chairman of the Board

Announcement of death of Chairman of the Board (Supplementary Statement on the circumstances of his deputy)

Announcement of change of director

Announcement of death of Chairman of the Board

OBI-866 ”Immunogenic/Therapeutic Glycan Compositions And Uses Thereof“ Was Granted By USPTO

Announcement on behalf of AP Biosciences to file application for Phase I human clinical trial of Bispecific Antibody, AP505, to US FDA

Announcement on behalf of AP Biosciences that it obtains the Internal Control Special Audit Report by CPA